Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $114.03 | $23.52 | 384.79% | 215.14x | 54.27x | 14.46x | 17.46x | 1.56x | $106.92M | 0.89% | $705.78M | 6.70 | $12.22B | 1,558.23 | ||
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | $25.29 | $8.04 | 214.73% | 120.43x | 56.54x | 7.11x | 14.41x | 1.03x | $39.15M | 1.19% | $220.58M | 1.69 | $3.26B | 71.78 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $75.22 | $16.95 | 343.90% | 70.30x | 64.35x | 6.94x | 8.97x | 1.80x | $182.84M | 3.13% | $654.15M | 8.43 | $5.70B | 47.54 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $231.18 | $78.73 | 193.65% | 37.90x | 34.28x | 6.43x | 22.84x | 1.31x | $793.95M | 2.57% | $1.35B | 10.14 | $32.21B | 27.31 | ||
| KRYS | KRYSTAL BIOTECH INC | $325.31 | $82.15 | 296.01% | 39.34x | 41.68x | 21.81x | 7.08x | 2.10x | $257.78M | 2.68% | $1.36B | 46.03 | $9.21B | 39.48 | ||
| VCEL | VERICEL CORP | $39.44 | $7.82 | 404.22% | 82.17x | 70.47x | 6.58x | 5.46x | 2.02x | $61.66M | 3.06% | $370.04M | 7.25 | $1.99B | 45.11 | ||
| RPRX | ROYALTY PHARMA PLC | $57.63 | $35.40 | 62.81% | 30.65x | 10.54x | 10.11x | 3.39x | 0.62x | $2.92B | 11.40% | $9.79B | 21.99 | $41.29B | 35.11 | ||
| HALO | HALOZYME THERAPEUTICS INC | $106.94 | $69.62 | 53.60% | 30.04x | 11.84x | 7.54x | 84.56x | 0.58x | $806.22M | 6.43% | $143.54M | 1.22 | $14.12B | 19.65 | ||
| TGTX | TG THERAPEUTICS INC | $53.62 | $21.93 | 144.45% | 17.41x | 53.95x | 9.51x | 13.59x | 1.94x | $17.39M | 0.23% | $604.08M | 4.26 | $8.48B | 60.89 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $58.44 | $18.23 | 220.54% | 153.79x | 20.20x | 3.32x | 1.79x | 1.02x | $738.18M | 6.53% | $6.32B | 32.68 | $14.62B | 37.92 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $10.18 | $7.45 | 36.71% | 10.72x | 9.36x | 4.43x | 2.78x | 0.93x | $82.01M | 13.61% | $217.65M | 3.68 | $460.70M | 5.96 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $233.01 | $176.37 | 32.11% | 15.27x | 9.12x | 3.20x | 3.15x | 0.63x | $1.62B | 11.00% | $4.80B | 75.98 | $17.90B | 11.07 | ||
| EXEL | EXELIXIS INC | $57.94 | $29.36 | 97.37% | 17.61x | 17.51x | 5.97x | 7.79x | 1.16x | $1.17B | 8.07% | $1.84B | 7.35 | $14.24B | 13.09 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $506.74 | $145.16 | 249.09% | 29.24x | 26.47x | 10.21x | 6.34x | 2.19x | $3.80B | 2.95% | $20.25B | 79.81 | $124.27B | 22.58 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $302.74 | $84.00 | 260.42% | 30.06x | 32.05x | 20.91x | 6.24x | 2.28x | $130.62M | 2.15% | $967.52M | 48.22 | $6.16B | 22.08 | ||
| MDXG | MIMEDX GROUP INC | $4.64 | $1.25 | 272.50% | 116.00x | -26.76x | 1.93x | 3.13x | 1.26x | $44.50M | 6.49% | $216.00M | 1.46 | $557.70M | 24.45 | ||
| ADMA | ADMA BIOLOGICS INC | $9.93 | $6.83 | 45.45% | 13.79x | 12.48x | 4.42x | 5.45x | 0.80x | $116.47M | 5.14% | $408.21M | 1.79 | $2.29B | 9.81 | ||
| UTHR | UNITED THERAPEUTICS CORP | $571.38 | $184.55 | 209.61% | 18.89x | 21.38x | 7.72x | 3.83x | 3.47x | $1.09B | 4.49% | $6.40B | 150.24 | $22.70B | 13.54 | ||
| TECH | BIO-TECHNE CORP | $72.40 | $15.93 | 354.43% | 61.88x | 34.85x | 9.29x | 5.39x | 1.97x | $263.22M | 2.33% | $2.11B | 13.52 | $11.38B | 32.73 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $734.81 | $418.67 | 75.51% | 17.52x | 13.10x | 4.86x | 2.39x | 0.93x | $3.76B | 4.98% | $31.71B | 308.48 | $75.90B | 13.20 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $39.57 | $29.44 | 34.39% | 12.60x | 9.49x | 2.39x | 2.31x | 0.75x | $354.90M | 15.48% | $999.24M | 17.25 | $1.91B | 6.82 | ||
| SPRO | SPERO THERAPEUTICS INC | $1.26 | $1.36 | -7.22% | 9.00x | -2.84x | 1.55x | 1.66x | 0.50x | $19.58M | 26.83% | $44.20M | 0.76 | $24.64M | 3.22 | ||
| VCYT | VERACYTE INC | $44.19 | $11.47 | 285.12% | 30.69x | 22.72x | 6.29x | 2.56x | 2.58x | $165.99M | 4.70% | $1.39B | 17.36 | $3.29B | 23.56 | ||
| INCY | INCYTE CORP | $117.14 | $57.64 | 103.24% | 14.43x | 33.04x | 4.03x | 3.74x | 1.62x | $1.92B | 8.18% | $6.34B | 31.66 | $19.79B | 9.57 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.